Cramer's lightning round: I like Eli Lilly over Biogen and Cassava Sciences
"Mad Money" host Jim Cramer answers callers' stock questions at rapid speed during Tuesday's edition of the lightning round. Sign up and learn more about the CNBC Investing Club with Jim Cramer https://www.cnbc.com/investingclub/x
Cassava Sciences: “This is not the one. I don’t think they have it. I don’t think Biogen has it, even though Medicare is going to pay for it. I think Eli Lilly has it, which is why we keep buying that one for the charitable trust.”
Root: “Roots is a really great restaurant in Summit, New Jersey. Root, the one that you’re referring to, is a not-so-great insurance technology company which I think is a [sell].”
Zeta Global: “There are so many of those. We’ve got so many of those. I’m going to tell you to buy Salesforce, OK? Just buy Salesforce, then we don’t have to fool around. We don’t have to worry about the new young ones. We can go with the established ones.”
Doximity: “I know the stock has been all over the place of late -- up and down, up and down. I remain convinced that the doctors love the product and therefore, [buy, buy, buy].”
ViacomCBS: “There’s been insider buying in ViacomCBS and that intrigues me, and I think the stock is not expensive at all.”
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: https://www.cnbc.com/2020/09/29/the-news-with-shepard-smith-podcast.html?__source=youtube%7Cshepsmith%7Cpodcast
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
https://www.cnbc.com/select/best-credit-cards/
#CNBC
#CNBCTV
Видео Cramer's lightning round: I like Eli Lilly over Biogen and Cassava Sciences канала CNBC Television
Cassava Sciences: “This is not the one. I don’t think they have it. I don’t think Biogen has it, even though Medicare is going to pay for it. I think Eli Lilly has it, which is why we keep buying that one for the charitable trust.”
Root: “Roots is a really great restaurant in Summit, New Jersey. Root, the one that you’re referring to, is a not-so-great insurance technology company which I think is a [sell].”
Zeta Global: “There are so many of those. We’ve got so many of those. I’m going to tell you to buy Salesforce, OK? Just buy Salesforce, then we don’t have to fool around. We don’t have to worry about the new young ones. We can go with the established ones.”
Doximity: “I know the stock has been all over the place of late -- up and down, up and down. I remain convinced that the doctors love the product and therefore, [buy, buy, buy].”
ViacomCBS: “There’s been insider buying in ViacomCBS and that intrigues me, and I think the stock is not expensive at all.”
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: https://www.cnbc.com/2020/09/29/the-news-with-shepard-smith-podcast.html?__source=youtube%7Cshepsmith%7Cpodcast
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
https://www.cnbc.com/select/best-credit-cards/
#CNBC
#CNBCTV
Видео Cramer's lightning round: I like Eli Lilly over Biogen and Cassava Sciences канала CNBC Television
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
![U.S. mid-caps are a great diversifier, says John Hancock's Emily Roland](https://i.ytimg.com/vi/4XmE9gg1-1w/default.jpg)
![Retail investors are joining in on the 'Magnificent 7' hype](https://i.ytimg.com/vi/cV_QFbLzim0/default.jpg)
![Opening Bell, November 4, 2022](https://i.ytimg.com/vi/JMXpeyy-Zc4/default.jpg)
![Nike: Here's why Oppenheimer upgraded the stock](https://i.ytimg.com/vi/Ll8hDyljwkA/default.jpg)
![Breaking down shares of Hilton, Expedia and Match Group](https://i.ytimg.com/vi/MPrkSqnures/default.jpg)
![Now is a time to own growth and sell some, says T. Rowe's Sebastien Page](https://i.ytimg.com/vi/Le-q3BIKnjw/default.jpg)
![Three-Stock Lunch: Tidewater, Progressive & CRH PLC](https://i.ytimg.com/vi/HeURMKJtvKI/default.jpg)
!['We expect moderation this year' in consumer spending, says NRF CEO Matt Shay](https://i.ytimg.com/vi/-UVxpWNqT1s/default.jpg)
![Existing home sales in May were essentially flat](https://i.ytimg.com/vi/OgBlrm3LNoA/default.jpg)
![Lockheed Martin sees record order volume in 2022 as earnings beat estimates](https://i.ytimg.com/vi/FAUB_hVp2uo/default.jpg)
![TD Cowen's Ritu Bara talks Sarepta stock skyrocketing on FDA gene therapy approval](https://i.ytimg.com/vi/rWrujfiVIAQ/default.jpg)
![A renter's experience of the housing market really depends on where they are right now: Igor Popov](https://i.ytimg.com/vi/4HiCjZkDvhk/default.jpg)
![CFRA's Sam Stovall: The projected S&P decline is due to the 10-year yield and inflation readings](https://i.ytimg.com/vi/mV0zSB4kBIE/default.jpg)
![CDK cyberattack hits U.S. auto dealers for third day in a row](https://i.ytimg.com/vi/TfaWMYJfMyQ/default.jpg)
![Compass CEO: Supply and demand indicators suggest a modest shift towards a homebuyer's market](https://i.ytimg.com/vi/n7oLtRwXaeY/default.jpg)
![Clean Start: This clean-tech startup transforms carbon emissions into vodka](https://i.ytimg.com/vi/nQdg79pWeNA/default.jpg)
![Calls of the Day: Palo Alto, Tesla and Freeport-McMoran](https://i.ytimg.com/vi/BqkAe7IaGKU/default.jpg)
![AI trade is at a 'short-term, tactical top', says Cantor Fitzgerald's Eric Johnston](https://i.ytimg.com/vi/vBmoCjCTeeQ/default.jpg)
![Prolonged high rates will be 'corrosive' to economy, says Moody's Mark Zandi](https://i.ytimg.com/vi/vmssJRLWCsQ/default.jpg)
![Venture capital veteran Alan Patricof: The startup business has never been better than it is now](https://i.ytimg.com/vi/XCWduR3xROg/default.jpg)
![Expect some rotation during earnings season, says Morgan Stanley's Chris Toomey](https://i.ytimg.com/vi/EoqYb6KDkMk/default.jpg)